{"id":3966,"date":"2022-04-14T10:00:00","date_gmt":"2022-04-14T10:00:00","guid":{"rendered":"https:\/\/preprod.treefrog.fr\/?p=3966"},"modified":"2022-05-06T07:32:40","modified_gmt":"2022-05-06T07:32:40","slug":"treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires","status":"publish","type":"post","link":"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/","title":{"rendered":"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3966\" class=\"elementor elementor-3966\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a3a38c6 elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"a3a38c6\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-17d5eea\" data-id=\"17d5eea\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-04730d9 elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"04730d9\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-c820012\" data-id=\"c820012\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-dba84a5 elementor-widget elementor-widget-text-editor\" data-id=\"dba84a5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><strong>Elsy Boglioli, <\/strong>ancienne directrice des op\u00e9rations de la soci\u00e9t\u00e9 de th\u00e9rapie cellulaire Cellectis, fondatrice and directrice g\u00e9n\u00e9rale de la soci\u00e9t\u00e9 de conseil en biotechnologie Bio-Up, est nomm\u00e9e administratrice ind\u00e9pendante et pr\u00e9sidente du comit\u00e9 strat\u00e9gique.<\/li><li><b>Dr Melissa Carpenter,<\/b> directrice scientifique de la division m\u00e9decine r\u00e9g\u00e9n\u00e9rative de la soci\u00e9t\u00e9 am\u00e9ricaine de th\u00e9rapie cellulaire et g\u00e9nique ElevateBio, est nomm\u00e9e administratrice ind\u00e9pendante du comit\u00e9 strat\u00e9gique.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9574dc8 elementor-widget elementor-widget-text-editor\" data-id=\"9574dc8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Bordeaux, le 14 Avril 2022\u00a0<\/strong>\u00a0\u2013 <a href=\"https:\/\/preprod.treefrog.fr\/fr\">TreeFrog Therapeutics<\/a>, une soci\u00e9t\u00e9 de biotechnologie fran\u00e7aise visant \u00e0 rendre les th\u00e9rapies cellulaires issues de cellules souches plus s\u00fbres, plus efficaces et plus abordables pour des millions de patients, annonce aujourd&rsquo;hui la nomination de deux nouvelles administratrices ind\u00e9pendants: Elsy Boglioli, ancienne directrice des op\u00e9rations de Cellectis, fondatrice et directrice g\u00e9n\u00e9rale du cabinet de conseil en biotechnologie <a href=\"https:\/\/bio-up.life\/\">Bio-Up<\/a>, et Dr Melissa Carpenter, directrice scientifique de la division m\u00e9decine r\u00e9g\u00e9n\u00e9rative de <a href=\"https:\/\/www.elevate.bio\/\">ElevateBio<\/a>, une entreprise technologique am\u00e9ricaine de th\u00e9rapie cellulaire et g\u00e9nique. Elsy Boglioli est \u00e9galement nomm\u00e9e pr\u00e9sidente du comit\u00e9 strat\u00e9gique.<\/p><p><em>\u00ab Suite \u00e0 notre seconde lev\u00e9e de fonds, nous avons accueilli de nouveaux investisseurs au sein du conseil d\u2019administration : Bpifrance Large Venture, Leonard Green &amp; Partners et Bristol Myers Squibb. Je suis ravi de renforcer notre organisation avec de nouveaux administrateurs ind\u00e9pendants, pour guider notre strat\u00e9gie et porter notre ambition. Elsy, forte d\u2019une connaissance approfondie du secteur des biotechnologies, pr\u00e9sidera notre comit\u00e9 strat\u00e9gique, apportant une nouvelle dynamique \u00e0 notre gouvernance et \u00e0 nos efforts d\u2019industrialisation. Melissa est une experte mondialement reconnue des th\u00e9rapies cellulaires d\u00e9riv\u00e9es de cellules souches pluripotentes induites, qui renforcera notre r\u00e9seau am\u00e9ricain et nous aidera \u00e0 piloter nos programmes vers les phases cliniques. Je tiens \u00e9galement \u00e0 remercier chaleureusement notre co-fondateur Jean-Luc Treillou, pour son travail en tant que pr\u00e9sident du comit\u00e9 strat\u00e9gique durant les premi\u00e8res ann\u00e9es de l&rsquo;entreprise. \u00bb<\/em> <br \/>Dr Fr\u00e9d\u00e9ric Desdouits, pr\u00e9sident de TreeFrog Therapeutics.<\/p><p class=\"MsoNormal\">\u201cJe suis ravie de rejoindre TreeFrog au moment o\u00f9<br \/>l&rsquo;entreprise lance le d\u00e9ploiement d\u2019une plateforme technologique unique et<br \/>entre dans une nouvelle phase de croissance. Ensemble, nous voulons affronter des d\u00e9fis majeurs pour le d\u00e9veloppement des th\u00e9rapies cellulaires, et concevoir des traitements transformateurs, avec des \u00e9chelles et des niveaux de qualit\u00e9 industriels, capables d\u2019apporter des solutions th\u00e9rapeutiques \u00e0 un tr\u00e8s grand nombre de patients.\u00a0\u00bb Dr Melissa Carpenter, directrice scientifique m\u00e9decine r\u00e9g\u00e9n\u00e9rative, ElevateBio.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c80dec4 elementor-widget elementor-widget-spacer\" data-id=\"c80dec4\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-21916fc elementor-widget elementor-widget-video\" data-id=\"21916fc\" data-element_type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/youtu.be\\\/uJKKbYIVRs0&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-152d743 elementor-widget elementor-widget-text-editor\" data-id=\"152d743\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"text-align: center; size: 9;\"><em>Interview de Elsy Boglioli, pr\u00e9sidente du comit\u00e9 strat\u00e9gique de <br \/>TreeFrog Therapeutics<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-237edc9 elementor-widget elementor-widget-text-editor\" data-id=\"237edc9\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Elsy Boglioli, fondatrice et directrice g\u00e9n\u00e9rale, Bio-Up<br \/><\/strong>Elsy Boglioli a d\u00e9but\u00e9 sa carri\u00e8re en 2006 au sein du Boston Consulting Group o\u00f9 elle a \u00e9t\u00e9 associ\u00e9e, en charge de la division biotechnologies en Europe. En 2017, elle rejoint la soci\u00e9t\u00e9 de th\u00e9rapie cellulaire Cellectis en tant que vice-pr\u00e9sidente de la strat\u00e9gie et du d\u00e9veloppement commercial, avant de devenir directrice des op\u00e9rations. En 2019, elle fonde le cabinet de conseil ind\u00e9pendant Bio-Up. Dans le cadre de ses activit\u00e9s au sein de Bio-Up, elle a \u00e9t\u00e9 nomm\u00e9e aux conseils d&rsquo;administration de Gensight Biologics, OSE Immunotherapeutics, Metafora Biosystems, Inova, Kelindi et Womed. Polytechnicienne, Elsy Boglioli est \u00e9galement titulaire d&rsquo;une ma\u00eetrise en \u00e9conomie et gestion de l&rsquo;Universit\u00e9 Pompeu Fabra et a \u00e9t\u00e9 form\u00e9e en immuno-oncologie \u00e0 l&rsquo;Institut Gustave Roussy.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d21b8e5 elementor-widget elementor-widget-text-editor\" data-id=\"d21b8e5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Dr Melissa Carpenter, directrice scientifique m\u00e9decine r\u00e9g\u00e9nrative, ElevateBio<br><\/strong>Auteure de plus de 50 articles scientifiques et inventrice de 34 brevets, Melissa Carpenter travaille au d\u00e9veloppement de th\u00e9rapies cellulaires issues de cellules souches depuis 25 ans. Elle a commenc\u00e9 sa carri\u00e8re chez CytoTherapeutics (devenu StemCells, Inc) o\u00f9 elle a d\u00e9riv\u00e9 des cellules souches neurales humaines et a d\u00e9velopp\u00e9 un milieu de culture permettant d\u2019industrialiser leur production. Elle a ensuite rejoint la biotech californienne de th\u00e9rapie cellulaire Geron en 1998 en tant que directrice de la biologie des cellules souches, pour d\u00e9velopper des programmes pr\u00e9cliniques en m\u00e9decine r\u00e9g\u00e9n\u00e9rative. Apr\u00e8s une parenth\u00e8se universitaire au Canada, elle int\u00e8gre en 2004 Novocell (maintenant Viacyte Inc.) en tant que vice-pr\u00e9sidente de la recherche et du d\u00e9veloppement, faisant avancer un nouveau programme de th\u00e9rapie cellulaire pour le traitement du diab\u00e8te fond\u00e9 sur des cellules souches pluripotentes humaines encapsul\u00e9es. Elle fonde ensuite son propre cabinet de conseil &#8211; Carpenter Group Consulting -, intervenant dans le d\u00e9veloppement de plus de 75 produits de th\u00e9rapie cellulaire et g\u00e9nique. En 2019, elle est nomm\u00e9e directrice scientifique de la division m\u00e9decine r\u00e9g\u00e9n\u00e9rative d&rsquo;ElevateBio, une entreprise technologique am\u00e9ricaine r\u00e9unissant des plateformes technologiques int\u00e9gr\u00e9es en \u00e9dition de g\u00e9n\u00e9tique, cellules souches pluripotentes induites (iPSC) et ing\u00e9nierie de prot\u00e9ines, vecteurs et cellules, ax\u00e9e sur la d\u00e9couverte, le d\u00e9veloppement et la fabrication de th\u00e9rapies cellulaires et g\u00e9niques transformatrices. Initialement form\u00e9e en psychologie, Melissa Carpenter a obtenu son doctorat au Laboratoire de neurobiologie cellulaire et mol\u00e9culaire de l&rsquo;Universit\u00e9 de Californie en 1989.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0babc46 elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"0babc46\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3afbf88\" data-id=\"3afbf88\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9cdc6d2 elementor-widget elementor-widget-spacer\" data-id=\"9cdc6d2\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b9b7211 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"b9b7211\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7b67d89 elementor-widget elementor-widget-text-editor\" data-id=\"7b67d89\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4><strong>A PROPOS DE TREEFROG THERAPEUTICS<\/strong><\/h4><p>TreeFrog Therapeutics est une soci\u00e9t\u00e9 de biotechnologie bas\u00e9e en France qui vise \u00e0 donner acc\u00e8s aux th\u00e9rapies cellulaires \u00e0 des millions de patients. TreeFrog Therapeutics d\u00e9veloppe un pipeline de th\u00e9rapies cellulaires fond\u00e9 sur la technologie propri\u00e9taire C-Stem<sup>TM<\/sup>, permettant la production en masse de cellules souches pluripotentes induites et leur diff\u00e9renciation en microtissus pr\u00eats-\u00e0-greffer, \u00e0 des \u00e9chelles et des niveaux de qualit\u00e9 cellulaire sans pr\u00e9c\u00e9dent. R\u00e9unissant plus de 80 biophysiciens, biologistes cellulaires et ing\u00e9nieurs en bioproduction, TreeFrog Therapeutics a lev\u00e9 plus de 70 millions d\u2019euros au cours des 3 derni\u00e8res ann\u00e9es pour faire progresser son pipeline de th\u00e9rapies cellulaire dans le domaine des maladie neurod\u00e9g\u00e9n\u00e9ratives, des troubles cardio-m\u00e9taboliques et de l\u2019immuno-oncologie. La soci\u00e9t\u00e9 ouvre cette ann\u00e9e des hubs technologiques \u00e0 Boston, aux \u00c9tats-Unis, et \u00e0 Kobe, au Japon, pour stimuler l\u2019adoption de C-Stem<sup>TM<\/sup>\u00a0et initier des partenariats de co-d\u00e9veloppement avec des acteurs universitaires, biotechnologiques et industriels de premier plan dans le domaine de la th\u00e9rapie cellulaire.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bb04a2f elementor-widget elementor-widget-text-editor\" data-id=\"bb04a2f\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4><strong>CONTACT MEDIA<\/strong><\/h4>\n<p><strong>TreeFrog Therapeutics<\/strong><\/p>\n<p>Pierre-Emmanuel Gaultier &#8211; +33 645 774 258 &#8211;&nbsp;<a href=\"mailto:pierre@treefrog.fr\">pierre@treefrog.fr<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and gene editing, the newly created SAB will guide the development of proprietary C-StemTM technology platform and in-house cell therapy programs. <\/p>\n","protected":false},"author":1,"featured_media":3991,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[15,19],"tags":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires - TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires - TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous\" \/>\n<meta property=\"og:description\" content=\"TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and gene editing, the newly created SAB will guide the development of proprietary C-StemTM technology platform and in-house cell therapy programs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/\" \/>\n<meta property=\"og:site_name\" content=\"TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-14T10:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-06T07:32:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/preprod.treefrog.fr\/fr\/wp-content\/uploads\/sites\/2\/2022\/04\/photo-cp-board-3-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Piergueritona\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/\",\"url\":\"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/\",\"name\":\"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires - TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous\",\"isPartOf\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/#website\"},\"datePublished\":\"2022-04-14T10:00:00+00:00\",\"dateModified\":\"2022-05-06T07:32:40+00:00\",\"author\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\"},\"breadcrumb\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/preprod.treefrog.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/#website\",\"url\":\"https:\/\/preprod.treefrog.fr\/fr\/\",\"name\":\"TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous\",\"description\":\"Cell Therapy for All\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/preprod.treefrog.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\",\"name\":\"Piergueritona\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/preprod.treefrog.fr\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"caption\":\"Piergueritona\"},\"sameAs\":[\"https:\/\/preprod.treefrog.fr\"],\"url\":\"https:\/\/preprod.treefrog.fr\/fr\/author\/piergueritona\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires - TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires - TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous","og_description":"TreeFrog Therapeutics, a French-based biotech aimed at making safer, more efficient and more affordable off-the-shelf cell therapies based on induced pluripotent stem cells (iPSCs), today announces the formation of its Scientific Advisory Board (SAB). Bringing together world-class experts in biophysics, pluripotent stem cell biology and gene editing, the newly created SAB will guide the development of proprietary C-StemTM technology platform and in-house cell therapy programs.","og_url":"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/","og_site_name":"TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous","article_published_time":"2022-04-14T10:00:00+00:00","article_modified_time":"2022-05-06T07:32:40+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/preprod.treefrog.fr\/fr\/wp-content\/uploads\/sites\/2\/2022\/04\/photo-cp-board-3-scaled.jpg","type":"image\/jpeg"}],"author":"Piergueritona","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/","url":"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/","name":"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires - TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous","isPartOf":{"@id":"https:\/\/preprod.treefrog.fr\/fr\/#website"},"datePublished":"2022-04-14T10:00:00+00:00","dateModified":"2022-05-06T07:32:40+00:00","author":{"@id":"https:\/\/preprod.treefrog.fr\/fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220"},"breadcrumb":{"@id":"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/preprod.treefrog.fr\/fr\/treefrog-therapeutics-nomme-deux-administratrices-independantes-issues-de-l-industrie-des-therapies-cellulaires\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/preprod.treefrog.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Treefrog Therapeutics nomme deux administratrices ind\u00e9pendantes issues de l\u2019industrie des th\u00e9rapies cellulaires"}]},{"@type":"WebSite","@id":"https:\/\/preprod.treefrog.fr\/fr\/#website","url":"https:\/\/preprod.treefrog.fr\/fr\/","name":"TreeFrog Therapeutics I Les th\u00e9rapies cellulaires pour tous","description":"Cell Therapy for All","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/preprod.treefrog.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/preprod.treefrog.fr\/fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220","name":"Piergueritona","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/preprod.treefrog.fr\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","caption":"Piergueritona"},"sameAs":["https:\/\/preprod.treefrog.fr"],"url":"https:\/\/preprod.treefrog.fr\/fr\/author\/piergueritona\/"}]}},"_links":{"self":[{"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/posts\/3966"}],"collection":[{"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/comments?post=3966"}],"version-history":[{"count":27,"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/posts\/3966\/revisions"}],"predecessor-version":[{"id":4058,"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/posts\/3966\/revisions\/4058"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/media\/3991"}],"wp:attachment":[{"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/media?parent=3966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/categories?post=3966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/fr\/wp-json\/wp\/v2\/tags?post=3966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}